The global automated suturing devices market size was valued at USD 3.63 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 7.3 % from 2024 to 2030. The market growth worldwide is driven by the increasing prevalence of chronic diseases and the adoption of minimally invasive surgeries, which requires precise suturing techniques. Automated suturing devices, a critical component in open and minimally invasive procedures, enhance efficiency and accuracy in various medical fields, including orthopedics, gynecology, ophthalmology, and cardiovascular procedures.
The WHO anticipates that, by 2050, 80% of older adults will be residing in low and middle-income countries. This demographic trend indicates an increase in geriatric population, leading to rising demand in the industry. The rise in chronic conditions such as cardiovascular diseases, diabetes, and obesity necessitates more surgical interventions, thereby boosting the demand for automated suturing devices. Furthermore, the shift towards minimally invasive surgical techniques, which offer reduced recovery times, lower risk of infection, and less postoperative pain, is also driving the market.
Every year, approximately 1.19 million people die due to road traffic crashes, and between 20 and 50 million more suffer non-fatal injuries globally, according to WHO estimates. Industry growth is driven by cost efficiency and growing surgical volume. Automated suturing devices streamline the suturing process, reducing overall surgical time and hospital costs, making them an attractive option for healthcare providers seeking to optimize resources and improve patient throughput. This trend is expected to drive significant growth in various medical fields.
Regulatory and reimbursement support is also a key driver of the automated suturing devices market. Favorable reimbursement policies and regulatory approvals for automated suturing devices are encouraging their adoption in surgical practices. This support helps mitigate financial barriers for hospitals and clinics, facilitating market growth. Furthermore, rising awareness among healthcare professionals regarding the benefits of automated suturing devices, including enhanced patient outcomes and reduced complication rates, is driving their acceptance in surgical settings.
The segment of reusable automated suturing devices dominated the market in 2023, capturing the highest revenue share of 56.4%. This can be attributed to the devices’ exceptional infection resistance during procedures and their efficient sterilization methods, which significantly reduce tissue injury. Moreover, these devices are highly affordable and easily accessible in the market, further fueling the growth of this segment in the forecast period.
The disposable segment is projected to exhibit the fastest CAGR of 7.5% over the forecast period. The global surge in surgical procedures, driven by an aging population and chronic diseases, has created a demand for efficient and effective suturing solutions. Disposable automated suturing devices are gaining popularity due to their ability to minimize hospital-acquired infections, eliminating concerns related to sterilization processes. This trend is reinforced by the heightened awareness of infection control, post-COVID-19 pandemic.
The cardiac segment accounted for the largest revenue share of 26.8% in 2023, driven by the increasing prevalence of cardiovascular disorders and rising surgical procedures. The American Heart Association forecasts a 46% increase in heart failure cases by 2030. The orthopedic market is also growing, fueled by the aging population and rising sports-related injuries and trauma cases.
The dental segment is projected to exhibit the fastest CAGR of 8.7% over the forecast period. Automated suturing devices streamline the suturing process, reducing intervention time and improving patient outcomes. Precise automation minimizes human error, while integration of advanced technologies such as robotics and computer-assisted systems facilitates adoption.
Hospitals led the market with a revenue share of approximately 50.0% in 2023. The rise in hospital admissions is a key factor driving the demand for this segment. Moreover, the easy accessibility of hospitals, along with favorable reimbursement policies, is anticipated to further propel market growth. Handheld automated suturing devices are crucial for closing wounds in confined spaces, leading to quicker recovery and shorter hospital stays.
The ambulatory surgical centers segment is projected to exhibit the fastest CAGR of 7.5% over the forecast period. The preference for automatic suturing devices in ambulatory care centers and clinics is increasing due to their ability to reduce turnaround time and promote quick recovery. These devices are widely available and extensively used in emergency care, contributing to the anticipated market growth.
North America automated suturing devices market emerged as the dominant player in the global automated suturing devices market, accounting for the largest revenue share of 34.6%. The regional market is driven by the growing elderly population and increasing surgical procedures. In addition, the preference for robot-assisted minimally invasive surgeries and continuous technological advancements in automated suturing devices are expected to boost demand.
The automated suturing devices market in the U.S. dominated the North America automated suturing devices market with 71.5% of the total revenue share in 2023. Market growth is driven by the high prevalence of chronic diseases such as cardiovascular disease, diabetes, and obesity, resulting in increased demand for surgeries. The well-established healthcare system and favorable reimbursement policies for cutting-edge medical technologies also contribute to market growth, making these devices more accessible to healthcare facilities and enhancing their adoption.
Europe automated suturing devices market is a lucrative region, driven by factors such as the development of surgical instruments, increasing minimally invasive surgeries, and aging population. Investments in healthcare infrastructure enhancement, including surgery upgrades and technology adoption, are also contributing to market growth.
The automated suturing devices market in the UK is poised for significant growth, driven by rising surgical procedure volumes across general surgery, gynecology, and orthopedics. Minimally invasive surgeries also contribute to demand, as automated suturing devices improve precision and reduce operation time, critical factors in enhancing patient outcomes.
The Asia Pacificautomated suturing devices market region is projected to experience the the fastest growth of 8.1% from 2024 to 2030. The region is experiencing a surge in chronic diseases, including cardiovascular disorders, diabetes, and cancer, driving a corresponding increase in surgical procedures. The aging population and growing demand for minimally invasive surgeries, which offer benefits such as reduced recovery time and lower risk of complications, are also contributing to market growth.
The automated suturing devices market in India is expected to grow at a significant CAGR during forecast period. The rise in surgical procedures, particularly in the fields of orthopedics, cardiology, and general surgery, is expected to propel the adoption of automated suturing devices. Moreover, the growing prevalence of chronic diseases increases the demand for efficient surgical interventions, thereby boosting market demand. Government initiatives aimed at improving healthcare infrastructure and increasing investments in medical technology are also contributing to the market growth.
Some key companies in ambulance stretchers market include Medtronic; Boston Scientific Corporation; BD; and others. The industry is marked by a diverse landscape of established multinational corporations and emerging companies, each seeking to innovate and gain market share through cutting-edge technologies and strategic partnerships.
Medtronic specializes in developing and manufacturing a range of medical devices, including automated suturing devices. The company is committed to research and development, introducing advanced technologies to facilitate minimally invasive surgeries, improving surgical outcomes and enhancing patient safety.
Boston Scientific Corporation is dedicated to developing innovative solutions across various medical fields, including endoscopy, urology, and cardiology. Its automated suturing devices enhance surgical efficiency and patient outcomes through precise and rapid suturing during minimally invasive procedures.
The following are the leading companies in the automated suturing devices market. These companies collectively hold the largest market share and dictate industry trends.
In November 2023, Ethicon, a company under Johnson & Johnson, introduced ETHIZIA, a hemostatic patch, clinically proven to stop bleeding in 30 seconds, 80% faster than the leading fibrin sealant patch.
In August 2023, Healthium Medtech launched TRUMAS, a pioneering range of sutures, addressing challenges in minimal access surgeries and providing surgeons with innovative solutions to enhance patient care and improve outcomes.
Report Attribute |
Details |
Market size value in 2024 |
USD 3.86 billion |
Revenue forecast in 2030 |
USD 5.90 billion |
Growth rate |
CAGR of 7.3% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, end use, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Key companies profiled |
Medtronic; Boston Scientific Corporation; BD; LSI Solutions, Inc; Smith+Nephew; Sutrue; Medical Device Business Services, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2020 to 2030. For the purpose of this study, Grand View Research has segmented the global automated suturing devices market report based on product, application, end use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Disposable
Reusable
Application Outlook (Revenue, USD Million, 2018 - 2030)
Cardiac
Orthopedic
Gastrointestinal
Ophthalmic
Dental
Gynecological
Other Applications
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Other End Users
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."